Header
 
Login
 

Privatsphäre-Einstellungen

Wir verwenden Cookies auf unserer Website. Einige von ihnen sind unerlässlich, während andere uns helfen, diese Website und Ihre Erfahrungen zu verbessern.

Notwendig Statistik Marketing
Auswahl bestätigen
Weitere Einstellungen

Hier finden Sie eine Übersicht aller verwendeten Cookies. Sie können ganzen Kategorien Ihre Zustimmung geben oder weitere Informationen anzeigen und bestimmte Cookies auswählen.

Alle auswählen
Auswahl bestätigen
Notwendig Cookies
Wesentliche Cookies ermöglichen grundlegende Funktionen und sind für die ordnungsgemäße Funktion der Website erforderlich.
Statistik Cookies
Statistik-Cookies sammeln anonym Informationen. Diese Informationen helfen uns zu verstehen, wie unsere Besucher unsere Website nutzen.
Marketing Cookies
Marketing-Cookies werden von Werbekunden oder Publishern von Drittanbietern verwendet, um personalisierte Anzeigen zu schalten. Sie tun dies, indem sie Besucher über Websites hinweg verfolgen
Zurück

Ihr Suchergebnis

Sie recherchieren derzeit unangemeldet.
Melden Sie sich an (Login) um den vollen Funktionsumfang der Datenbank nutzen zu können.
Sie suchen in allen Bereichen nach dem Autor Götze E.

In der Rubrik Zeitschriften haben wir 3 Beiträge für Sie gefunden

  1. Merken

    Should Package Leaflets be Coloured in the Future?

    Rubrik: Originale

    (Treffer aus pharmind, Nr. 10, Seite 1428 (2018))

    Fuchs J | Götze E | Voigt C

    Should Package Leaflets be Coloured in the Future? / Readability Test Results from the PAINT3 Study · Fuchs J, Götze E, Voigt C · 1PAINT-Consult®, Jena und Department of Drug Regulatory Affairs at the Institute of Pharmacy, Bonn und University of Bonn
    package leaflet coloured patient information readability test package insert test QRD template For decades, package leaflets have been in regular use to communicate risks and the safe use of medicines in the European Union [ 1 – 4 ] – given that they must be delivered to patients in direct conjunction with medicines, in accordance with Article 58 of Directive 2001/83/EC. Regarding its content, “the package leaflet shall be drawn up in accordance with the summary of the product characteristics” with information being ordered as stated in Article 59(1) of this directive. Articles 59(3) and 63(2) instruct that the package leaflet must be ...

  2. Merken

    Landscape Versus Portrait Format in Package Leaflets

    Rubrik: Originale

    (Treffer aus pharmind, Nr. 08, Seite 1178 (2016))

    Fuchs J | Götze E | Voigt C

    Landscape Versus Portrait Format in Package Leaflets / Which Format Is More Suitable According to Readability Test Results From the PAINT3 Study? · Fuchs J, Götze E, Voigt C · 1PAINT-Consult®, Jena, Germany und 2Department of Drug Regulatory Affairs at the Institute of Pharmacy, University of Bonn, Bonn, Germany
    package leaflet package insert readability test landscape format portrait format Within the European Union, package leaflets are the most frequently used resource for patient information concerning medicines – given that they are included with every medicine package. Article  59(3) of Directive 2001/83/EC demands that package leaflets shall be “… legible, clear and easy to use .” [ 1 ]. To ensure this aim, article 65(c) of the quoted directive mandates the European Commission to “... draw up and publish detailed guidance concerning in particular… the legibility of particulars on the labelling and package leaflet ” – the so called readability guideline. ...

  3. Merken

    The Influence of the European Union's QRD Template on the Use of Package Inserts Compared with a Shorter Model Template

    Rubrik: Originale

    (Treffer aus pharmind, Nr. 01, Seite 126 (2012))

    Fuchs J | Scheunpflug C | Götze E

    The Influence of the European Union's QRD Template on the Use of Package Inserts Compared with a Shorter Model Template / Fuchs et al. • Templates for Package Inserts · Fuchs J, Scheunpflug C, Götze E · 1 PAINT-Consult®, Jena, Germany und 2 Department of Drug Regulatory Affairs, Institute of Pharmacy, University of Bonn, Germany
    Package insert Package insert test Patient information QRD template Readability test Clear and easily understandable medicine package inserts are essential constituents in ensuring safe and successful therapeutic outcomes for patients [ 1-4 ]. Therefore, over time, various directives and guidelines were published worldwide in efforts to achieve a consistently high quality in comprehensibility, layout and design of patient information [ 5-10 ]. In some regions, including Australia and the European Union, text frameworks are additionally recommended [ 11 , 12 ]. The QRD template, generated by the Quality Review of Documents (QRD) Working Group – a part of the European ...